相关实验视频

Updated: Jul 9, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

发现了用于癌症免疫治疗的选择性TC-PTP降解剂

Jinmin Miao¹, Jiajun Dong¹, Yiming Miao¹

¹Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University West Lafayette IN 47907 USA zhang-zy@purdue.edu.

Chemical science

|November 29, 2023

概括

研究人员开发了TP1L,这是用于癌症免疫治疗的第一个强大的T细胞蛋白氨酸酸酶 (TC-PTP) 降解剂. TP1L增强了免疫细胞信号传递和瘤细胞杀伤,提供了一个新的治疗策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物化学生物化学

背景情况:

T细胞蛋白氨酸酸酶 (TC-PTP) 是免疫细胞功能的关键调节剂.
TC-PTP失调与癌症的发展和进展有关.
准TC-PTP是癌症免疫疗法的有希望的策略.

研究的目的:

发现和描述用于癌症免疫治疗的新型TC-PTP抑制剂.
在临床前模型中评估一种新型TC-PTP降解剂TP1L的疗效.

主要方法:

合理的药物设计和系统的查,以确定TC-PTP降解剂.
生物化学试验以评估TC-PTP降解和基质酸化.
基于细胞的测试来评估免疫细胞激活和抗瘤功效.

主要成果:

发现TP1L,一种强效和选择性的TC-PTP PROTAC降解剂.
TP1L诱导TC-PTP降解,增强干扰素-马信号传递,并增加MHC-I表达.
TP1L激活T细胞受体信号,并增强CAR-T细胞介导的瘤杀伤.

结论:

TP1L是一种有前途的第一级TC-PTP降解剂,用于癌症免疫治疗.
TP1L有助于更深入地了解TC-PTP生物学.
TP1L作为开发新型免疫治疗剂的有价值的起点.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...